FDA Inspection
Megafine Pharma (P) LimitedMegafine Pharma (P) Limited – FDA Inspection, Jan 24, 2023
Record Details
This FDA Inspection record concerns Megafine Pharma (P) Limited, with an inspection on January 24, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 5d607a40-9c0f-4492-9ad3-5f8e69123f40
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1195646
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Megafine Pharma (P) Limited
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 6, 2020 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 12, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 15, 2015 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 2, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Megafine Pharma (P) Limited
- FDA Inspection 1122874 - 2020-03-06
- FDA Inspection 1054711 - 2018-05-12
- FDA Inspection 929021 - 2015-05-15
- FDA Inspection 730085 - 2011-06-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.